Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Prothena reported $13.74M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.

Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 101.24M 3.17M
Agios Pharmaceuticals AGIO:US USD 28.37M 4.4M
Akebia Therapeutics AKBA:US USD 25.22M 5.43M
Alnylam Pharmaceuticals ALNY:US USD 183.66M 26.68M
Amgen AMGN:US USD 1.26B 210M
Biogen BIIB:US USD 605M 27.8M
BioMarin Pharmaceutical BMRN:US USD 223M 22.74M
Bluebird Bio BLUE:US USD 37.35M 6.65M
Exelixis EXEL:US USD 131.4M 12.15M
Immunic Inc. VTL:US USD 4.29M 666K
Incyte Corp INCY:US USD 315.61M 42.79M
Intercept Pharmaceuticals ICPT:US USD 57.66M 2.37M
Intra Cellular Therapies ITCI:US USD 98.92M 4.29M
Ionis Pharmaceuticals IONS:US USD 45.52M 2.43M
MacroGenics MGNX:US USD 13.53M 145K
Nektar Therapeutics NKTR:US USD 21.08M 858K
Neurocrine Biosciences NBIX:US USD 242.7M 59.8M
Prothena PRTA:US USD 13.74M 614K
Regeneron Pharmaceuticals REGN:US USD 601.1M 59.4M
Seattle Genetics SGEN:US USD 206.44M 9.66M
Ultragenyx Pharmaceutical RARE:US USD 76.65M 3.8M
Vertex Pharmaceuticals VRTX:US USD 241.1M 26.3M
Xoma XOMA:US USD 6.2M 1.38M